• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Predictive Genetic Testing and Consumer Wellness Genomics Market Analysis

    ID: MRFR/LS/9360-HCR
    120 Pages
    Rahul Gotadki
    October 2025

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screen...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    ReportInfographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Predictive Genetic Testing and Consumer Wellness Genomics Market Industry Landscape

    Due to genomic technologies, public awareness, and a desire for individualized treatment, predictive genetic testing and consumer wellness genomics are increasing rapidly. These marketplaces provide genetic testing that reveal a person's lifestyle, illness propensity, and general health. Rising consumer knowledge and participation in genetics drives market dynamics. A consumer-driven industry for predictive genetic testing and wellness genomics has grown as people seek proactive health solutions. Direct-to-consumer genetic testing is growing. DTC services enable consumers to get genetic information without healthcare practitioner participation, increasing accessibility, convenience, and market growth. Disease risk is the main focus of predictive genetic testing. The growth of genetic test disease indicators, from common ailments like cardiovascular disease to uncommon genetic abnormalities, provides consumers with complete health information and shapes market dynamics. Market dynamics depend on genome sequencing advances. Due to lower sequencing costs, increased accuracy, and efficiency, genetic testing is now more accessible to a broader audience, driving market expansion. The predictive genetic testing and wellness genomics industry is affected by AI and data analytics. These technologies improve genetic data interpretation, enabling more nuanced and individualized disease risk, nutritional, and lifestyle insights and commercial innovation. Regulations and genetic privacy concerns affect market dynamics. To earn customer confidence and comply with changing regulatory norms, market actors are installing stronger privacy protections to assure ethical genetic data usage. Lifestyle optimization is part of consumer wellness genomics beyond illness risk assessment. Genetic testing that provides insights into diet, exercise, sleep habits, and other lifestyle aspects is becoming more popular, allowing people to make healthy decisions. Healthcare provider-genetic testing company partnerships are influencing the industry. These collaborations incorporate genetic information into the healthcare ecosystem to provide tailored and preventative treatment and increase clinical genetic testing. Predictive genetic testing and consumer wellness genomics markets are global. As awareness and technology improve, the worldwide market expands. Market dynamics are diversifying as emerging economies shine. Educational attempts to improve genetic literacy affect the market. Genetic counseling services are increasingly essential to the market, providing full genetic test findings and enabling informed decision-making. Looking forward, the predictive genetic testing and consumer wellness genomics business is positioned for continuous innovation. Genetic data integration with digital health platforms, testing panel extension, and genomic interpretation of non-coding areas may be future developments. As these markets evolve, technology advances, legislative changes, and genomics' inclusion into mainstream healthcare and lifestyle practices will affect the dynamics.

    Market Summary

    Key Market Trends & Highlights

    Market Trends

    Predictive Genetic Testing and Consumer Wellness Genomics Market Market Drivers

    Market Segment Insights

    Regional Insights

    Industry Developments

      • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
      • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
      • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
      • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
      • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.

    Market Segmentation

    Europe

    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Asia-Pacific

    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Test Type

    • Predictive Testing
    • Consumer Genomics
    • Wellness Genomics

    North America

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Rest of the World

    • Middle East
    • Africa
    • Latin America 

    By Application type

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Colon Cancer
    • Others

    List of companies covered in this report:

    • 23andMe, Inc. (California)
    • Myriad Genetics, Inc. (US)
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Abbott Laboratories (US)
    • Genesis Genetics (US)
    • Agilent Technologies (US)
    • Thermo Fisher Scientific, Inc. (US)
    • Bureau Gravimétrique International (China)
    • Bio-Rad Laboratories Inc. (US)
    • Illumina, Inc. (US)
    • Counsyl, Inc. (California)
    • ARUP Laboratories  (US)
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments

    • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
    • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
    • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
    • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
    • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type

    • Wellness Genomics
    • Nutria Genetic
    • Skin & Metabolism Genetics
    • Others
    • Consumer Genomics
    • Predictive Testing
    • Genetic Susceptibility Test
    • Predictive Diagnostic
    • Population Screening

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Diabetic Screening & Monitoring
    • Colon Cancer
    • Parkinsonism/Alzheimer’s Disease
    • Urologic Screening/Prostate Cancer Screening
    • Orthopedic & Musculoskeletal
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 11.2 Billion
      CAGR   5.4%
      Base Year   2022
      Forecast Period   2023-2032
      Historical Data   2021
      Forecast Units   Value (USD Billion)
      Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Test Type, Application, and Setting Type
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
      Key Vendors   23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US)
      Key Market Opportunities   Rise of application in personalized medicine
      Key Market Drivers   Usage of predictive genetic testing & consumer/wellness genomics in various applications

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

    The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

    Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

    North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

    What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

    High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

    1. EXECUTIVE SUMMARY
    2. MARKET INTRODUCTION
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. RESEARCH METHODOLOGY
      1. Data Mining
      2. Secondary Research
      3. Primary Research
        1. Primary Interviews and Information Gathering Process
        2. Breakdown
      4. Forecasting Application
      5. Market Size Estimation
        1. Bottom-Up Approach
        2. Top-Down Approach
      6. Data Triangulation
      7. Validation
    4. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    5. MARKET FACTOR ANALYSIS
      1. Bargaining Power of Suppliers
        1. Bargaining Power of Buyers
        2. Threat of New Entrants
        3. Intensity of Rivalry
      2. Value Chain Analysis
      3. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Impact
        3. Regional Impact
        4. Opportunity and Threat Analysis
    6. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. Overview
      2. Predictive Testing
        1. Genetic
        2. Predictive Diagnostic
        3. Population Screening
      3. Consumer Genomics
      4. Wellness Genomics
        1. Nutria Genetic
        2. Skin & Metabolism Genetics
        3. Others
    7. GLOBAL PREDICTIVE
      1. Breast & Ovarian Cancer
      2. Cardiovascular Screening
      3. Diabetic Screening & Monitoring
      4. Colon Cancer
      5. Parkinsonism/Alzheimer’s
      6. Urologic Screening/Prostate Cancer Screening
      7. Orthopedic
      8. Others
    8. GLOBAL PREDICTIVE GENETIC TESTING
      1. Overview
      2. Metabolic Testing
      3. Genomic Testing
      4. Overview
      5. North America
        1. US
        2. Canada
        3. Germany
        4. France
        5. UK
        6. Italy
        7. Spain
        8. Rest of Europe
      6. Asia-Pacific
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
      7. Rest of the World
        1. Middle East
        2. Africa
        3. Latin America
    9. COMPANY LANDSCAPE
      1. Competitive Analysis
      2. Market Share Analysis
      3. Competitive Benchmarking
      4. Leading Players in
      5. Key developments and Growth Strategies
        1. New
        2. Merger & Acquisitions
      6. Major Players
        1. Sales & Operating Income,
        2. Major Players R&D Expenditure. 2020
    10. COMPANY PROFILES
      1. 23andMe, Inc.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Myriad Genetics, Inc.
      3. F.Hoffmann-La
      4. Abbott Laboratories
      5. Genesis Genetics
      6. Thermo Fisher Scientific, Inc.
      7. Bureau
      8. Bio-Rad Laboratories Inc.
      9. Counsyl, Inc.
      10. ARUP Laboratories
    11. APPENDIX
      1. References
      2. Related Reports
    12. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE,
    13. (%)
    14. GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT
    15. COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT
    16. ARUP LABORATORIES: SWOT ANALYSIS

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials